In recent trading session, Soleno Therapeutics, Inc. (NASDAQ:SLNO) saw 1,334,930 shares changing hands at last check today with its beta currently measuring 0.42. Company’s recent
During the last session, Soleno Therapeutics, Inc. (NASDAQ:SLNO)’s traded shares were 1,074,803, with the beta value of the company hitting 0.42. At the end of
In the last trading session, 1,690,350 shares of the Soleno Therapeutics, Inc.(NASDAQ:SLNO) were traded, and its beta was 0.42. Most recently the company’s share price
Soleno Therapeutics, Inc. (NASDAQ:SLNO)’s traded shares stood at 1,222,648 during the last session, with the company’s beta value hitting 0.41. At the close of trading,
In last trading session, Soleno Therapeutics, Inc. (NASDAQ:SLNO) saw 1,576,481 shares changing hands with its beta currently measuring 0.44. Company’s recent per share price level
Soleno Therapeutics, Inc. (NASDAQ:SLNO) has a beta value of 0.44 and has seen 1,367,488 shares traded in the last trading session. The company, currently valued
During the last session, Soleno Therapeutics, Inc. (NASDAQ:SLNO)’s traded shares were 2,442,463, with the beta value of the company hitting 0.44. At the end of
In the last trading session, 1,687,930 shares of the Soleno Therapeutics, Inc.(NASDAQ:SLNO) were traded, and its beta was 0.44. Most recently the company’s share price